Solution-Focused Brief Therapy for Cancer Survivors
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on therapy for psychological distress, so it's best to discuss your medications with the trial coordinators.
What data supports the effectiveness of the treatment Solution-Focused Brief Therapy for cancer survivors?
Is Solution-Focused Brief Therapy safe for humans?
How is Solution-Focused Brief Therapy different from other treatments for cancer survivors?
Solution-Focused Brief Therapy (SFBT) is unique because it focuses on the strengths and resources of cancer survivors to help them achieve positive changes, rather than concentrating on their problems. This approach is different from traditional therapies that often focus on analyzing and solving problems.13456
What is the purpose of this trial?
This clinical trial evaluates the how well a virtually delivered solution-focused brief therapy (SFBT-C) works to decrease adolescent and young adult cancer survivors' psychological distress in comparison to enhanced treatment-as-usual care. Cancer and its treatment can have immediate and long-term impacts on adolescent and young adult cancer survivor's lives, including education and employment, financial stability, sexual health, and social, romantic, and family relationships. Consequently, many adolescent and young adult cancer survivors report psychological distress, often manifesting as depression and anxiety, and may benefit from psychotherapy to improve their engagement with medical treatment and overall quality of life. SFBT-C is a theory-driven and brief hope-based psychotherapy designed for the unique psychosocial needs facing adolescent and young adult cancer survivors. Undergoing SFBT-C may work better than treatment-as-usual care for the support of psychological distress in adolescent and young adult cancer survivors.
Research Team
Anao Zhang
Principal Investigator
University of Michigan Rogel Cancer Center
Eligibility Criteria
This trial is for adolescent and young adult cancer survivors experiencing psychological distress. Participants should be dealing with the long-term impacts of cancer on their lives, such as challenges in education, employment, finances, sexual health, and relationships.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo virtual SFBT sessions or receive eTAU over 4-8 weeks
Follow-up
Participants are monitored for psychological distress and quality of life improvements post-intervention
Treatment Details
Interventions
- Solution-Focused Brief Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan Rogel Cancer Center
Lead Sponsor
Children's Cancer Research Fund
Collaborator
Children's Cancer Research Fund
Collaborator